Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection

AIDS. 2001 Jan 26;15(2):275-7. doi: 10.1097/00002030-200101260-00020.
No abstract available

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Didanosine / therapeutic use*
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV Reverse Transcriptase / genetics
  • HIV-1* / genetics
  • Humans
  • Lamivudine / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Time Factors
  • Viral Load
  • Zidovudine / therapeutic use*

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zidovudine
  • HIV Reverse Transcriptase
  • Didanosine